• Pestle and CriticalPoint Announce Partnership to Connect Compounding Education with Pharmacy Compliance Management

    Pestle, a pharmacy compliance and compounding workflow software, today announced a partnership with CriticalPoint by TRC Healthcare to connect compounding education with the training and compliance activities pharmacies manage in Pestle. Through the partnership, Pestle clients can purchase CriticalPoint education programs and access relevant courses directly from their Pestle training assignments.The partnership brings together CriticalPoint’s compounding education and Pestle’s tools
  • Solid Tumor Therapeutics: What’s New?

    Solid Tumor Therapeutics: What’s New?
    Originally published by our sister publication Specialty Pharmacy ContinuumHeather Ipema, PharmD, BCPSClinical Associate Professor, Drug Information SpecialistUniversity of Illinois Chicago Retzky College of PharmacySolid tumors are among the most common tumor types, comprising 8 of the top 10 most common cancers in men and women.1 Estimates for 2026 list lung cancer, colorectal cancer, and skin melanoma as the most likely new cancer diagnoses in men, and breast, lung, and colorectal as the most

Follow @newsl_pharmacy on Twitter!